Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.2519438112395433e-46,156.6856796116505,16411.205023176153,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",8.812767728459162e-44,0,0,67
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.151090809699997e-24,36.02009132420091,1962.953316094127,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",2.9147280471434957e-22,0,0,41
3,Nonalcoholic fatty liver disease WP4396,1.5439627719974565e-19,20.10096153846154,870.6684137941583,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",1.3947130373710355e-17,0,0,37
4,Mitochondrial complex I assembly model OXPHOS system WP4324,9.48902480420294e-13,inf,inf,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5']",6.428814304847492e-11,0,0,17
5,Oxidative phosphorylation WP623,1.3963116801605456e-10,19.877717391304348,451.06549468192185,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'NDUFB2', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",7.568009306470157e-09,0,0,19
6,Mitochondrial CIV Assembly WP4922,1.7914785538376658e-07,14.489247311827956,225.0912446874951,"['COX8A', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",8.091511468166791e-06,0,0,14
7,Mitochondrial complex III assembly WP4921,2.33847291274415e-06,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",9.053230847909495e-05,0,0,8
8,Pyrimidine metabolism WP4022,0.010320831473977407,3.6234961075725405,16.572389015789646,"['NT5C', 'POLD4', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.3496181661809847,0,0,8
9,Nanoparticle triggered regulated necrosis WP2513,0.02667628235050049,12.15126050420168,44.03593002195426,"['TRADD', 'FADD', 'FTL']",0.7646627423124397,0,0,3
10,Nanomaterial induced apoptosis WP2507,0.032515758551768796,5.406315789473684,18.52220240160662,"['ENDOG', 'BAX', 'CYCS', 'FADD']",0.7646627423124397,0,0,4
11,Selenium Micronutrient Network WP15,0.03612516219480713,2.8459745762711863,9.450814592987106,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH']",0.7646627423124397,0,0,7
12,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0395028722965836,inf,inf,"['COX8A', 'GSTP1']",0.7646627423124397,0,0,2
13,CAMKK2  Pathway WP4874,0.0395028722965836,inf,inf,"['FIS1', 'MAP1LC3A']",0.7646627423124397,0,0,2
14,Cellular Proteostasis WP4918,0.0395028722965836,inf,inf,"['VBP1', 'PFDN5']",0.7646627423124397,0,0,2
15,p38 MAPK Signaling Pathway WP400,0.05690314123137961,6.072478991596639,17.40618252375965,"['TRADD', 'DDIT3', 'HRAS']",0.9836857455576523,0,0,3
16,Ferroptosis WP4313,0.0838379514234831,3.240421052631579,8.03258089205477,"['MAP1LC3A', 'GPX4', 'SAT2', 'FTL']",0.9836857455576523,0,0,4
17,Proteasome Degradation WP183,0.0838379514234831,3.240421052631579,8.03258089205477,"['PSMB6', 'H2AFZ', 'HLA-B', 'PSMB10']",0.9836857455576523,0,0,4
18,Copper homeostasis WP3286,0.09730209842978205,4.046218487394958,9.427424952353071,"['SCO2', 'COX17', 'ATOX1']",0.9836857455576523,0,0,3
19,Eukaryotic Transcription Initiation WP405,0.09730209842978205,4.046218487394958,9.427424952353071,"['TAF13', 'POLR2I', 'POLR2K']",0.9836857455576523,0,0,3
20,Gastric acid production WP2596,0.10284555648303596,8.083857442348009,18.38695094708415,"['CCK', 'VIP']",0.9836857455576523,0,0,2
21,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.10284555648303596,8.083857442348009,18.38695094708415,"['MAP1LC3A', 'FTL']",0.9836857455576523,0,0,2
22,TNF-alpha signaling pathway WP231,0.11853893955003279,2.6989473684210528,5.755542423851191,"['TRADD', 'BAX', 'FADD', 'HRAS']",0.9836857455576523,0,0,4
23,Cytosolic DNA-sensing pathway WP4655,0.11853893955003279,2.6989473684210528,5.755542423851191,"['TRADD', 'FADD', 'POLR2K', 'POLR2L']",0.9836857455576523,0,0,4
24,mRNA Processing WP411,0.11853893955003279,2.6989473684210528,5.755542423851191,"['LSM7', 'SNRPE', 'SRSF9', 'LSM2']",0.9836857455576523,0,0,4
25,DNA IR-double strand breaks and cellular response via ATM WP3959,0.14589187919883273,3.0330882352941178,5.838359651351359,"['DCLRE1C', 'KAT5', 'BAX']",0.9836857455576523,0,0,3
26,Leptin signaling pathway WP2034,0.14589187919883273,3.0330882352941178,5.838359651351359,"['RPS6', 'BAX', 'HRAS']",0.9836857455576523,0,0,3
27,Apoptosis Modulation by HSP70 WP384,0.1790148640250642,4.039832285115304,6.949668689223351,"['CYCS', 'FADD']",0.9836857455576523,0,0,2
28,GABA receptor Signaling WP4159,0.1790148640250642,4.039832285115304,6.949668689223351,"['SLC32A1', 'AP2M1']",0.9836857455576523,0,0,2
29,15q11.2 copy number variation syndrome WP4940,0.19892001843744964,inf,inf,['TUBGCP4'],0.9836857455576523,0,0,1
30,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.19892001843744964,inf,inf,['IDH3B'],0.9836857455576523,0,0,1
31,Vitamin B12 Disorders WP4271,0.19892001843744964,inf,inf,['CUBN'],0.9836857455576523,0,0,1
32,EV release from cardiac cells and their functional effects WP3297,0.19892001843744964,inf,inf,['RGS16'],0.9836857455576523,0,0,1
33,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.19892001843744964,inf,inf,['ELOB'],0.9836857455576523,0,0,1
34,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.19892001843744964,inf,inf,['MAP1LC3A'],0.9836857455576523,0,0,1
35,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.19892001843744964,inf,inf,['HRAS'],0.9836857455576523,0,0,1
36,Insulin signaling in adipocytes (diabetic condition) WP3635,0.19892001843744964,inf,inf,['RPS6'],0.9836857455576523,0,0,1
37,Insulin signaling in adipocytes (normal condition) WP3634,0.19892001843744964,inf,inf,['RPS6'],0.9836857455576523,0,0,1
38,LDLRAD4 and what we know about it WP4904,0.19892001843744964,inf,inf,['TGFBR2'],0.9836857455576523,0,0,1
39,Mitochondrial CII Assembly WP4920,0.19892001843744964,inf,inf,['SDHAF1'],0.9836857455576523,0,0,1
40,Nanoparticle triggered autophagic cell death WP2509,0.19892001843744964,inf,inf,['MAP1LC3A'],0.9836857455576523,0,0,1
41,Non-homologous end joining WP438,0.19892001843744964,inf,inf,['DCLRE1C'],0.9836857455576523,0,0,1
42,Phosphoinositides metabolism WP4971,0.19892001843744964,inf,inf,['PIP4P1'],0.9836857455576523,0,0,1
43,16p11.2 proximal deletion syndrome WP4949,0.20043144707339933,2.4252100840336133,3.8979989408499702,"['ASPHD1', 'SEZ6L2', 'CCT7']",0.9836857455576523,0,0,3
44,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.20043144707339933,2.4252100840336133,3.8979989408499702,"['PPP1R14B', 'MAP1LC3A', 'DDIT3']",0.9836857455576523,0,0,3
45,Apoptosis WP254,0.20212138835582283,2.022105263157895,3.2331174733562444,"['TRADD', 'CYCS', 'BAX', 'FADD']",0.9836857455576523,0,0,4
46,DNA Repair Pathways Full Network WP4946,0.20212138835582283,2.022105263157895,3.2331174733562444,"['POLD4', 'DCLRE1C', 'CENPX', 'APEX1']",0.9836857455576523,0,0,4
47,Head and Neck Squamous Cell Carcinoma WP4674,0.20212138835582283,2.022105263157895,3.2331174733562444,"['RPS6', 'FADD', 'HRAS', 'TGFBR2']",0.9836857455576523,0,0,4
48,Non-small cell lung cancer WP4255,0.25872819646093104,2.0199579831932772,2.7309371439686094,"['CYCS', 'BAX', 'HRAS']",0.9836857455576523,0,0,3
49,ATM Signaling Network in Development and Disease  WP3878,0.2604226834565754,2.691823899371069,3.6217124799014355,"['DCLRE1C', 'KAT5']",0.9836857455576523,0,0,2
50,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.2604226834565754,2.691823899371069,3.6217124799014355,"['HRAS', 'TGFBR2']",0.9836857455576523,0,0,2
51,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.2604226834565754,2.691823899371069,3.6217124799014355,"['LDHA', 'RPS6']",0.9836857455576523,0,0,2
52,IL-2 signaling pathway WP49,0.2604226834565754,2.691823899371069,3.6217124799014355,"['RPS6', 'HRAS']",0.9836857455576523,0,0,2
53,Interleukin-11 Signaling Pathway WP2332,0.2604226834565754,2.691823899371069,3.6217124799014355,"['RPS6', 'HRAS']",0.9836857455576523,0,0,2
54,MET in type 1 papillary renal cell carcinoma WP4205,0.2604226834565754,2.691823899371069,3.6217124799014355,"['RPL11', 'HRAS']",0.9836857455576523,0,0,2
55,Rett syndrome causing genes WP4312,0.2604226834565754,2.691823899371069,3.6217124799014355,"['IMPDH2', 'TBL1X']",0.9836857455576523,0,0,2
56,Ciliary landscape WP4352,0.2623284292559452,1.5166490486257929,2.029516078049969,"['EXOSC4', 'NDUFA5', 'COPS7A', 'MYL6B', 'COX6C', 'LSM4']",0.9836857455576523,0,0,6
57,Apoptosis Modulation and Signaling WP1772,0.27909987550292914,1.554690035702694,1.9840730119391143,"['ENDOG', 'TRADD', 'CYCS', 'BAX', 'FADD']",0.9836857455576523,0,0,5
58,IL-18 signaling pathway WP4754,0.2885947782810183,1.3054542953435586,1.6223294697713948,"['CD81', 'TMSB4X', 'RGS16', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'FADD', 'LTB', 'RND2']",0.9836857455576523,0,0,10
59,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.31880929865317914,1.7304921968787514,1.9782332059906238,"['APEX1', 'RPS6', 'HRAS']",0.9836857455576523,0,0,3
60,Endometrial cancer WP4155,0.31880929865317914,1.7304921968787514,1.9782332059906238,"['BAX', 'FGF1', 'HRAS']",0.9836857455576523,0,0,3
61,Hepatitis B infection WP4666,0.32194144343921527,1.4428872814948763,1.635347671090458,"['CYCS', 'BAX', 'FADD', 'HRAS', 'TGFBR2']",0.9836857455576523,0,0,5
62,Integrated breast cancer pathway WP1984,0.32194144343921527,1.4428872814948763,1.635347671090458,"['TRADD', 'BAX', 'FADD', 'FAU', 'TGFBR2']",0.9836857455576523,0,0,5
63,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3419829608816509,2.0178197064989516,2.165109174950228,"['CYCS', 'FADD']",0.9836857455576523,0,0,2
64,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3419829608816509,2.0178197064989516,2.165109174950228,"['BAX', 'FADD']",0.9836857455576523,0,0,2
65,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.3419829608816509,2.0178197064989516,2.165109174950228,"['TRADD', 'FADD']",0.9836857455576523,0,0,2
66,Serotonin and anxiety WP3947,0.3583370672511594,4.03347280334728,4.139477336645728,['CRH'],0.9836857455576523,0,0,1
67,Serotonin and anxiety-related events WP3944,0.3583370672511594,4.03347280334728,4.139477336645728,['CRH'],0.9836857455576523,0,0,1
68,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3583370672511594,4.03347280334728,4.139477336645728,['HRAS'],0.9836857455576523,0,0,1
69,Amyotrophic lateral sclerosis (ALS) WP2447,0.3583370672511594,4.03347280334728,4.139477336645728,['BAX'],0.9836857455576523,0,0,1
70,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.3583370672511594,4.03347280334728,4.139477336645728,['HRAS'],0.9836857455576523,0,0,1
71,Biomarkers for pyrimidine metabolism disorders WP4584,0.3583370672511594,4.03347280334728,4.139477336645728,['NT5C'],0.9836857455576523,0,0,1
72,Canonical and non-canonical TGF-B signaling WP3874,0.3583370672511594,4.03347280334728,4.139477336645728,['TGFBR2'],0.9836857455576523,0,0,1
73,Transcriptional cascade regulating adipogenesis WP4211,0.3583370672511594,4.03347280334728,4.139477336645728,['DDIT3'],0.9836857455576523,0,0,1
74,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3583370672511594,4.03347280334728,4.139477336645728,['CCK'],0.9836857455576523,0,0,1
75,Dual hijack model of Vif in HIV infection WP3300,0.3583370672511594,4.03347280334728,4.139477336645728,['ELOB'],0.9836857455576523,0,0,1
76,Ebstein-Barr virus LMP1 signaling WP262,0.3583370672511594,4.03347280334728,4.139477336645728,['TRADD'],0.9836857455576523,0,0,1
77,Energy Metabolism WP1541,0.3583370672511594,4.03347280334728,4.139477336645728,['UCP3'],0.9836857455576523,0,0,1
78,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.3583370672511594,4.03347280334728,4.139477336645728,['MAFF'],0.9836857455576523,0,0,1
79,Fatty acid transporters WP5061,0.3583370672511594,4.03347280334728,4.139477336645728,['FABP6'],0.9836857455576523,0,0,1
80,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.3583370672511594,4.03347280334728,4.139477336645728,['H2AFZ'],0.9836857455576523,0,0,1
81,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.3583370672511594,4.03347280334728,4.139477336645728,['RPS6'],0.9836857455576523,0,0,1
82,Glutathione metabolism WP100,0.3583370672511594,4.03347280334728,4.139477336645728,['GPX4'],0.9836857455576523,0,0,1
83,Homologous recombination WP186,0.3583370672511594,4.03347280334728,4.139477336645728,['POLD4'],0.9836857455576523,0,0,1
84,MAPK Cascade WP422,0.3583370672511594,4.03347280334728,4.139477336645728,['HRAS'],0.9836857455576523,0,0,1
85,MTHFR deficiency WP4288,0.3583370672511594,4.03347280334728,4.139477336645728,['CYCS'],0.9836857455576523,0,0,1
86,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3583370672511594,4.03347280334728,4.139477336645728,['SCO2'],0.9836857455576523,0,0,1
87,Peroxiredoxin 2 induced ovarian failure WP4873,0.3583370672511594,4.03347280334728,4.139477336645728,['BAX'],0.9836857455576523,0,0,1
88,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.3583370672511594,4.03347280334728,4.139477336645728,['LDHA'],0.9836857455576523,0,0,1
89,Alzheimer's disease WP2059,0.3790031496887125,1.5133928571428572,1.4683100392677149,"['ATP5MD', 'CYCS', 'FADD']",0.9836857455576523,0,0,3
90,Canonical and non-canonical Notch signaling WP3845,0.4204193654613252,1.6134171907756814,1.398030153050559,"['MAML2', 'DLK2']",0.9836857455576523,0,0,2
91,Computational Model of Aerobic Glycolysis WP4629,0.4204193654613252,1.6134171907756814,1.398030153050559,"['LDHA', 'PFKM']",0.9836857455576523,0,0,2
92,Kit receptor signaling pathway WP304,0.4204193654613252,1.6134171907756814,1.398030153050559,"['RPS6', 'HRAS']",0.9836857455576523,0,0,2
93,Modulators of TCR signaling and T cell activation WP5072,0.4204193654613252,1.6134171907756814,1.398030153050559,"['NDUFB10', 'ELOB']",0.9836857455576523,0,0,2
94,Oxidative Damage WP3941,0.4204193654613252,1.6134171907756814,1.398030153050559,"['C5AR1', 'CYCS']",0.9836857455576523,0,0,2
95,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4204193654613252,1.6134171907756814,1.398030153050559,"['TRADD', 'FADD']",0.9836857455576523,0,0,2
96,Acute viral myocarditis WP4298,0.43796371468682677,1.3445378151260505,1.110076255755479,"['ENDOG', 'CYCS', 'BAX']",0.9836857455576523,0,0,3
97,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.43796371468682677,1.3445378151260505,1.110076255755479,"['CYCS', 'BAX', 'TGFBR2']",0.9836857455576523,0,0,3
98,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.43796371468682677,1.3445378151260505,1.110076255755479,"['RPS6', 'BAX', 'HRAS']",0.9836857455576523,0,0,3
99,Genotoxicity pathway WP4286,0.43796371468682677,1.3445378151260505,1.110076255755479,"['RPS27', 'BLOC1S2', 'TRIAP1']",0.9836857455576523,0,0,3
100,16p11.2 distal deletion syndrome WP4950,0.4860827392966657,2.0156903765690375,1.4540715159529747,['CD81'],0.9836857455576523,0,0,1
101,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.4860827392966657,2.0156903765690375,1.4540715159529747,['VIP'],0.9836857455576523,0,0,1
102,Vitamin D-sensitive calcium signaling in depression WP4698,0.4860827392966657,2.0156903765690375,1.4540715159529747,['GPX4'],0.9836857455576523,0,0,1
103,EDA signaling in hair follicle development WP3930,0.4860827392966657,2.0156903765690375,1.4540715159529747,['LTB'],0.9836857455576523,0,0,1
104,Glycosylation and related congenital defects WP4521,0.4860827392966657,2.0156903765690375,1.4540715159529747,['DPM3'],0.9836857455576523,0,0,1
105,Histone Modifications WP2369,0.4860827392966657,2.0156903765690375,1.4540715159529747,['SET'],0.9836857455576523,0,0,1
106,IL17 signaling pathway WP2112,0.4860827392966657,2.0156903765690375,1.4540715159529747,['IL17RE'],0.9836857455576523,0,0,1
107,Interferon type I signaling pathways WP585,0.4860827392966657,2.0156903765690375,1.4540715159529747,['RPS6'],0.9836857455576523,0,0,1
108,Joubert Syndrome WP4656,0.4860827392966657,2.0156903765690375,1.4540715159529747,['KAT5'],0.9836857455576523,0,0,1
109,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.4860827392966657,2.0156903765690375,1.4540715159529747,['BAX'],0.9836857455576523,0,0,1
110,Nanoparticle-mediated activation of receptor signaling WP2643,0.4860827392966657,2.0156903765690375,1.4540715159529747,['HRAS'],0.9836857455576523,0,0,1
111,NO/cGMP/PKG mediated Neuroprotection WP4008,0.4860827392966657,2.0156903765690375,1.4540715159529747,['CYCS'],0.9836857455576523,0,0,1
112,Overview of nanoparticle effects WP3287,0.4860827392966657,2.0156903765690375,1.4540715159529747,['BAX'],0.9836857455576523,0,0,1
113,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.4860827392966657,2.0156903765690375,1.4540715159529747,['HRAS'],0.9836857455576523,0,0,1
114,Pyrimidine metabolism and related diseases WP4225,0.4860827392966657,2.0156903765690375,1.4540715159529747,['NT5C'],0.9836857455576523,0,0,1
115,RalA downstream regulated genes WP2290,0.4860827392966657,2.0156903765690375,1.4540715159529747,['HRAS'],0.9836857455576523,0,0,1
116,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4860827392966657,2.0156903765690375,1.4540715159529747,['ANAPC11'],0.9836857455576523,0,0,1
117,"Relationship between inflammation, COX-2 and EGFR WP4483",0.4860827392966657,2.0156903765690375,1.4540715159529747,['HRAS'],0.9836857455576523,0,0,1
118,Synaptic Vesicle Pathway WP2267,0.49374863465096513,1.3438155136268344,0.9483692131448899,"['SLC32A1', 'AP2M1']",0.9836857455576523,0,0,2
119,Base Excision Repair WP4752,0.49374863465096513,1.3438155136268344,0.9483692131448899,"['POLD4', 'APEX1']",0.9836857455576523,0,0,2
120,MECP2 and Associated Rett Syndrome WP3584,0.49374863465096513,1.3438155136268344,0.9483692131448899,"['SST', 'RPS6']",0.9836857455576523,0,0,2
121,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.49374863465096513,1.3438155136268344,0.9483692131448899,"['IFI27L2', 'HRAS']",0.9836857455576523,0,0,2
122,Prolactin Signaling Pathway WP2037,0.49374863465096513,1.3438155136268344,0.9483692131448899,"['RPS6', 'HRAS']",0.9836857455576523,0,0,2
123,Androgen receptor signaling pathway WP138,0.49466034956538224,1.209453781512605,0.8513150620470293,"['KAT5', 'BAG1', 'STUB1']",0.9836857455576523,0,0,3
124,22q11.2 copy number variation syndrome WP4657,0.5483483684223203,1.0989304812834224,0.6602863193099766,"['RANBP1', 'MRPL40', 'THAP7']",0.9836857455576523,0,0,3
125,Complement system WP2806,0.5483483684223203,1.0989304812834224,0.6602863193099766,"['FKBP2', 'RPS19', 'C5AR1']",0.9836857455576523,0,0,3
126,Thermogenesis WP4321,0.5608972881391644,1.1512428870919438,0.6656687579544713,"['RPS6', 'HRAS']",0.9836857455576523,0,0,2
127,Melanoma WP4685,0.5608972881391644,1.1512428870919438,0.6656687579544713,"['BAX', 'HRAS']",0.9836857455576523,0,0,2
128,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5608972881391644,1.1512428870919438,0.6656687579544713,"['LDHA', 'BAX']",0.9836857455576523,0,0,2
129,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5608972881391644,1.1512428870919438,0.6656687579544713,"['BAX', 'HRAS']",0.9836857455576523,0,0,2
130,BDNF-TrkB Signaling WP3676,0.588438616991774,1.3430962343096233,0.7122206463161885,['HRAS'],0.9836857455576523,0,0,1
131,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.588438616991774,1.3430962343096233,0.7122206463161885,['SST'],0.9836857455576523,0,0,1
132,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.588438616991774,1.3430962343096233,0.7122206463161885,['RPS6'],0.9836857455576523,0,0,1
133,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.588438616991774,1.3430962343096233,0.7122206463161885,['FADD'],0.9836857455576523,0,0,1
134,TP53 network WP1742,0.588438616991774,1.3430962343096233,0.7122206463161885,['BAX'],0.9836857455576523,0,0,1
135,Type 2 papillary renal cell carcinoma WP4241,0.588438616991774,1.3430962343096233,0.7122206463161885,['ELOB'],0.9836857455576523,0,0,1
136,Type II interferon signaling (IFNG) WP619,0.588438616991774,1.3430962343096233,0.7122206463161885,['HLA-B'],0.9836857455576523,0,0,1
137,White fat cell differentiation WP4149,0.588438616991774,1.3430962343096233,0.7122206463161885,['DDIT3'],0.9836857455576523,0,0,1
138,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.588438616991774,1.3430962343096233,0.7122206463161885,['HRAS'],0.9836857455576523,0,0,1
139,ERK Pathway in Huntington's Disease WP3853,0.588438616991774,1.3430962343096233,0.7122206463161885,['HRAS'],0.9836857455576523,0,0,1
140,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.588438616991774,1.3430962343096233,0.7122206463161885,['CD81'],0.9836857455576523,0,0,1
141,Genes targeted by miRNAs in adipocytes WP1992,0.588438616991774,1.3430962343096233,0.7122206463161885,['TMSB4X'],0.9836857455576523,0,0,1
142,Glycosaminoglycan degradation WP4815,0.588438616991774,1.3430962343096233,0.7122206463161885,['SGSH'],0.9836857455576523,0,0,1
143,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.588438616991774,1.3430962343096233,0.7122206463161885,['FGF1'],0.9836857455576523,0,0,1
144,HIF1A and PPARG regulation of glycolysis WP2456,0.588438616991774,1.3430962343096233,0.7122206463161885,['LDHA'],0.9836857455576523,0,0,1
145,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.588438616991774,1.3430962343096233,0.7122206463161885,['TGFBR2'],0.9836857455576523,0,0,1
146,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.588438616991774,1.3430962343096233,0.7122206463161885,['HRAS'],0.9836857455576523,0,0,1
147,Major receptors targeted by epinephrine and norepinephrine WP4589,0.588438616991774,1.3430962343096233,0.7122206463161885,['ADRA2A'],0.9836857455576523,0,0,1
148,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.588438616991774,1.3430962343096233,0.7122206463161885,['VEGFB'],0.9836857455576523,0,0,1
149,miRNA regulation of p53 pathway in prostate cancer WP3982,0.588438616991774,1.3430962343096233,0.7122206463161885,['BAX'],0.9836857455576523,0,0,1
150,Nucleotide metabolism WP404,0.588438616991774,1.3430962343096233,0.7122206463161885,['NME2'],0.9836857455576523,0,0,1
151,PDGF Pathway WP2526,0.588438616991774,1.3430962343096233,0.7122206463161885,['HRAS'],0.9836857455576523,0,0,1
152,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.588438616991774,1.3430962343096233,0.7122206463161885,['BAX'],0.9836857455576523,0,0,1
153,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.588438616991774,1.3430962343096233,0.7122206463161885,['BAX'],0.9836857455576523,0,0,1
154,SARS-CoV-2 mitochondrial interactions WP5038,0.588438616991774,1.3430962343096233,0.7122206463161885,['NDUFB9'],0.9836857455576523,0,0,1
155,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6214192377862026,1.0068134171907757,0.4789908023426501,"['HRAS', 'TGFBR2']",0.9836857455576523,0,0,2
156,TGF-beta Receptor Signaling WP560,0.6214192377862026,1.0068134171907757,0.4789908023426501,"['HRAS', 'TGFBR2']",0.9836857455576523,0,0,2
157,VEGFA-VEGFR2 Signaling Pathway WP3888,0.6314830514100059,0.9378494623655914,0.4311145574828232,"['SET', 'RPS6', 'RPL10A', 'RPL7', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'FADD', 'CCT7', 'HRAS']",0.9836857455576523,0,0,14
158,Endoderm differentiation WP2853,0.6449152570570685,0.9288946347769877,0.40744695698728345,"['DUSP4', 'TCEAL2', 'NME1']",0.9836857455576523,0,0,3
159,Gastrin signaling pathway WP4659,0.6449152570570685,0.9288946347769877,0.40744695698728345,"['KAT5', 'RPS6', 'HRAS']",0.9836857455576523,0,0,3
160,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6704425197370026,1.0067991631799162,0.4025357305119502,['RPS6'],0.9836857455576523,0,0,1
161,Vitamin A and carotenoid metabolism WP716,0.6704425197370026,1.0067991631799162,0.4025357305119502,['RBP4'],0.9836857455576523,0,0,1
162,DNA Replication WP466,0.6704425197370026,1.0067991631799162,0.4025357305119502,['POLD4'],0.9836857455576523,0,0,1
163,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6704425197370026,1.0067991631799162,0.4025357305119502,['MAP1LC3A'],0.9836857455576523,0,0,1
164,Glycolysis in senescence WP5049,0.6704425197370026,1.0067991631799162,0.4025357305119502,['LDHA'],0.9836857455576523,0,0,1
165,"GPCRs, Class B Secretin-like WP334",0.6704425197370026,1.0067991631799162,0.4025357305119502,['ADGRL4'],0.9836857455576523,0,0,1
166,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6704425197370026,1.0067991631799162,0.4025357305119502,['TGFBR2'],0.9836857455576523,0,0,1
167,IL-5 signaling pathway WP127,0.6704425197370026,1.0067991631799162,0.4025357305119502,['RPS6'],0.9836857455576523,0,0,1
168,Kallmann's Syndrome WP5074,0.6704425197370026,1.0067991631799162,0.4025357305119502,['CHD7'],0.9836857455576523,0,0,1
169,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6704425197370026,1.0067991631799162,0.4025357305119502,['OMG'],0.9836857455576523,0,0,1
170,PDGFR-beta pathway WP3972,0.6704425197370026,1.0067991631799162,0.4025357305119502,['HRAS'],0.9836857455576523,0,0,1
171,PPAR signaling pathway WP3942,0.6704425197370026,1.0067991631799162,0.4025357305119502,['FABP6'],0.9836857455576523,0,0,1
172,7q11.23 copy number variation syndrome WP4932,0.6752894284806183,0.8944793850454228,0.3511850372172663,"['ATP5F1E', 'ATP5MC1']",0.9836857455576523,0,0,2
173,B Cell Receptor Signaling Pathway WP23,0.6752894284806183,0.8944793850454228,0.3511850372172663,"['CD81', 'HRAS']",0.9836857455576523,0,0,2
174,DNA damage response WP707,0.6752894284806183,0.8944793850454228,0.3511850372172663,"['CYCS', 'BAX']",0.9836857455576523,0,0,2
175,miRNA regulation of DNA damage response WP1530,0.6752894284806183,0.8944793850454228,0.3511850372172663,"['CYCS', 'BAX']",0.9836857455576523,0,0,2
176,Pancreatic adenocarcinoma pathway WP4263,0.6752894284806183,0.8944793850454228,0.3511850372172663,"['BAX', 'TGFBR2']",0.9836857455576523,0,0,2
177,EGF/EGFR signaling pathway WP437,0.6873774147614209,0.862094837935174,0.32317501878857346,"['NDUFA13', 'HRAS', 'AP2M1']",0.9836857455576523,0,0,3
178,NRF2 pathway WP2884,0.7002211264278516,0.8465373961218836,0.30167130368923234,"['GSTP1', 'MAFF', 'FTL', 'TGFBR2']",0.9836857455576523,0,0,4
179,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7227545175254468,0.8046121593291404,0.26124602004889474,"['RPS6', 'HRAS']",0.9836857455576523,0,0,2
180,Exercise-induced Circadian Regulation WP410,0.7227545175254468,0.8046121593291404,0.26124602004889474,"['GSTP1', 'UCP3']",0.9836857455576523,0,0,2
181,Glycolysis and Gluconeogenesis WP534,0.7227545175254468,0.8046121593291404,0.26124602004889474,"['LDHA', 'PFKM']",0.9836857455576523,0,0,2
182,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7361343505456547,0.8050209205020921,0.2466122303465417,['HRAS'],0.9836857455576523,0,0,1
183,Alpha 6 Beta 4 signaling pathway WP244,0.7361343505456547,0.8050209205020921,0.2466122303465417,['HRAS'],0.9836857455576523,0,0,1
184,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7361343505456547,0.8050209205020921,0.2466122303465417,['HRAS'],0.9836857455576523,0,0,1
185,Translation Factors WP107,0.7361343505456547,0.8050209205020921,0.2466122303465417,['EEF1B2'],0.9836857455576523,0,0,1
186,Vitamin B12 metabolism WP1533,0.7361343505456547,0.8050209205020921,0.2466122303465417,['CUBN'],0.9836857455576523,0,0,1
187,Cori Cycle WP1946,0.7361343505456547,0.8050209205020921,0.2466122303465417,['LDHA'],0.9836857455576523,0,0,1
188,DNA Mismatch Repair WP531,0.7361343505456547,0.8050209205020921,0.2466122303465417,['POLD4'],0.9836857455576523,0,0,1
189,IL-6 signaling pathway WP364,0.7361343505456547,0.8050209205020921,0.2466122303465417,['VIP'],0.9836857455576523,0,0,1
190,Integrated Cancer Pathway WP1971,0.7361343505456547,0.8050209205020921,0.2466122303465417,['BAX'],0.9836857455576523,0,0,1
191,Integrin-mediated Cell Adhesion WP185,0.7361343505456547,0.8050209205020921,0.2466122303465417,['HRAS'],0.9836857455576523,0,0,1
192,Nephrotic syndrome WP4758,0.7361343505456547,0.8050209205020921,0.2466122303465417,['CUBN'],0.9836857455576523,0,0,1
193,Nucleotide Excision Repair WP4753,0.7361343505456547,0.8050209205020921,0.2466122303465417,['POLD4'],0.9836857455576523,0,0,1
194,One-carbon metabolism and related pathways WP3940,0.7361343505456547,0.8050209205020921,0.2466122303465417,['GPX4'],0.9836857455576523,0,0,1
195,Pathways affected in adenoid cystic carcinoma WP3651,0.7361343505456547,0.8050209205020921,0.2466122303465417,['HRAS'],0.9836857455576523,0,0,1
196,MAPK Signaling Pathway WP382,0.7416977686384392,0.8033755274261604,0.24005940390665062,"['DUSP4', 'DDIT3', 'FGF1', 'HRAS', 'TGFBR2']",0.9836857455576523,0,0,5
197,Myometrial relaxation and contraction pathways WP289,0.7633483985155505,0.7651127819548872,0.20661161818837928,"['RGS16', 'MAFF', 'CRH', 'IGFBP6']",0.9836857455576523,0,0,4
198,DNA damage response (only ATM dependent) WP710,0.7642261289295655,0.7310844291976367,0.19658242778586474,"['BAX', 'HRAS']",0.9836857455576523,0,0,2
199,AGE/RAGE pathway WP2324,0.7887534332443523,0.6705020920502092,0.1591111604907449,['CYCS'],0.9836857455576523,0,0,1
200,Aryl Hydrocarbon Receptor Netpath WP2586,0.7887534332443523,0.6705020920502092,0.1591111604907449,['HRAS'],0.9836857455576523,0,0,1
201,Toll-like Receptor Signaling Pathway WP75,0.7887534332443523,0.6705020920502092,0.1591111604907449,['FADD'],0.9836857455576523,0,0,1
202,Unfolded protein response WP4925,0.7887534332443523,0.6705020920502092,0.1591111604907449,['DDIT3'],0.9836857455576523,0,0,1
203,Folate Metabolism WP176,0.7887534332443523,0.6705020920502092,0.1591111604907449,['GPX4'],0.9836857455576523,0,0,1
204,G Protein Signaling Pathways WP35,0.7887534332443523,0.6705020920502092,0.1591111604907449,['HRAS'],0.9836857455576523,0,0,1
205,Heart Development WP1591,0.7887534332443523,0.6705020920502092,0.1591111604907449,['VEGFB'],0.9836857455576523,0,0,1
206,IL-3 signaling pathway WP286,0.7887534332443523,0.6705020920502092,0.1591111604907449,['HRAS'],0.9836857455576523,0,0,1
207,Lung fibrosis WP3624,0.7887534332443523,0.6705020920502092,0.1591111604907449,['FGF1'],0.9836857455576523,0,0,1
208,Notch Signaling Pathway Netpath WP61,0.7887534332443523,0.6705020920502092,0.1591111604907449,['MAML2'],0.9836857455576523,0,0,1
209,p53 transcriptional gene network WP4963,0.7887534332443523,0.6705020920502092,0.1591111604907449,['BAX'],0.9836857455576523,0,0,1
210,Parkinson's disease pathway WP2371,0.7887534332443523,0.6705020920502092,0.1591111604907449,['CYCS'],0.9836857455576523,0,0,1
211,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7887534332443523,0.6705020920502092,0.1591111604907449,['GSTP1'],0.9836857455576523,0,0,1
212,Photodynamic therapy-induced unfolded protein response WP3613,0.7887534332443523,0.6705020920502092,0.1591111604907449,['DDIT3'],0.9836857455576523,0,0,1
213,Pre-implantation embryo WP3527,0.7887534332443523,0.6705020920502092,0.1591111604907449,['DDIT3'],0.9836857455576523,0,0,1
214,Retinoblastoma gene in cancer WP2446,0.7887534332443523,0.6705020920502092,0.1591111604907449,['H2AFZ'],0.9836857455576523,0,0,1
215,Small cell lung cancer WP4658,0.8002056988587544,0.6698113207547169,0.14929187468101032,"['CYCS', 'BAX']",0.9836857455576523,0,0,2
216,Regulation of Actin Cytoskeleton WP51,0.8002056988587544,0.6698113207547169,0.14929187468101032,"['TMSB4X', 'FGF1']",0.9836857455576523,0,0,2
217,Breast cancer pathway WP4262,0.8193713800597342,0.6691176470588235,0.13330017396053329,"['BAX', 'FGF1', 'HRAS']",0.9836857455576523,0,0,3
218,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8308968943070875,0.5744172145845786,0.10641053974142692,['TMSB4X'],0.9836857455576523,0,0,1
219,Bladder cancer WP2828,0.8308968943070875,0.5744172145845786,0.10641053974142692,['HRAS'],0.9836857455576523,0,0,1
220,Differentiation Pathway WP2848,0.8308968943070875,0.5744172145845786,0.10641053974142692,['FGF1'],0.9836857455576523,0,0,1
221,ErbB signaling pathway WP673,0.8308968943070875,0.5744172145845786,0.10641053974142692,['HRAS'],0.9836857455576523,0,0,1
222,Fragile X Syndrome  WP4549,0.8308968943070875,0.5744172145845786,0.10641053974142692,['AP2M1'],0.9836857455576523,0,0,1
223,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8308968943070875,0.5744172145845786,0.10641053974142692,['DDIT3'],0.9836857455576523,0,0,1
224,Monoamine GPCRs WP58,0.8308968943070875,0.5744172145845786,0.10641053974142692,['ADRA2A'],0.9836857455576523,0,0,1
225,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8308968943070875,0.5744172145845786,0.10641053974142692,['NDUFA13'],0.9836857455576523,0,0,1
226,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8312326041797136,0.6179648443799387,0.11422809141960268,"['HRAS', 'TGFBR2']",0.9836857455576523,0,0,2
227,ESC Pluripotency Pathways WP3931,0.8312326041797136,0.6179648443799387,0.11422809141960268,"['FGF1', 'HRAS']",0.9836857455576523,0,0,2
228,Oncostatin M Signaling Pathway WP2374,0.8312326041797136,0.6179648443799387,0.11422809141960268,"['RPS6', 'HRAS']",0.9836857455576523,0,0,2
229,Pathways in clear cell renal cell carcinoma WP4018,0.8312326041797136,0.6179648443799387,0.11422809141960268,"['LDHA', 'PFKM']",0.9836857455576523,0,0,2
230,Ciliopathies WP4803,0.8578493101125717,0.5735250074872716,0.0879367679733442,"['CCDC65', 'CCDC28B']",0.9922907773513299,0,0,2
231,Ebola Virus Pathway on Host WP4217,0.8578493101125717,0.5735250074872716,0.0879367679733442,"['HLA-B', 'VPS11']",0.9922907773513299,0,0,2
232,Ras signaling WP4223,0.8578493101125717,0.5735250074872716,0.0879367679733442,"['RASAL1', 'HRAS']",0.9922907773513299,0,0,2
233,Aryl Hydrocarbon Receptor Pathway WP2873,0.8646467639126426,0.5023535564853556,0.07305939809024468,['BAX'],0.9922907773513299,0,0,1
234,Complement and Coagulation Cascades WP558,0.8646467639126426,0.5023535564853556,0.07305939809024468,['C5AR1'],0.9922907773513299,0,0,1
235,Phosphodiesterases in neuronal function WP4222,0.8646467639126426,0.5023535564853556,0.07305939809024468,['PDE10A'],0.9922907773513299,0,0,1
236,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8646467639126426,0.5023535564853556,0.07305939809024468,['BAX'],0.9922907773513299,0,0,1
237,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8717253011071296,0.6458418402068872,0.08866176611148792,"['COL11A1', 'RPS6', 'VEGFB', 'FGF1', 'HRAS']",0.9922907773513299,0,0,5
238,Sleep regulation WP3591,0.8916719642266947,0.44630404463040446,0.051171868183641674,['CRH'],0.9922907773513299,0,0,1
239,Amino Acid metabolism WP3925,0.8916719642266947,0.44630404463040446,0.051171868183641674,['LDHA'],0.9922907773513299,0,0,1
240,Chemokine signaling pathway WP3929,0.8916719642266947,0.44630404463040446,0.051171868183641674,['HRAS'],0.9922907773513299,0,0,1
241,Ectoderm Differentiation WP2858,0.8916719642266947,0.44630404463040446,0.051171868183641674,['TBL1X'],0.9922907773513299,0,0,1
242,Metabolic reprogramming in colon cancer WP4290,0.8916719642266947,0.44630404463040446,0.051171868183641674,['LDHA'],0.9922907773513299,0,0,1
243,Regulation of toll-like receptor signaling pathway WP1449,0.8916719642266947,0.44630404463040446,0.051171868183641674,['FADD'],0.9922907773513299,0,0,1
244,Senescence and Autophagy in Cancer WP615,0.8999110466105944,0.5013102725366876,0.05286785932099177,"['MAP1LC3A', 'HRAS']",0.9922907773513299,0,0,2
245,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8999110466105944,0.5013102725366876,0.05286785932099177,"['RPS6', 'HRAS']",0.9922907773513299,0,0,2
246,Spinal Cord Injury WP2431,0.9007510377432737,0.5463139801375095,0.05710422119386543,"['APEX1', 'OMG', 'LTB']",0.9922907773513299,0,0,3
247,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.913310138807842,0.40146443514644353,0.03640470025614254,['RBP4'],0.9940042072968882,0,0,1
248,Glioblastoma signaling pathways WP2261,0.913310138807842,0.40146443514644353,0.03640470025614254,['HRAS'],0.9940042072968882,0,0,1
249,Mesodermal commitment pathway WP2857,0.913310138807842,0.40146443514644353,0.03640470025614254,['RPL38'],0.9940042072968882,0,0,1
250,T-cell receptor (TCR) signaling pathway WP69,0.9306332998647109,0.36477748193229365,0.02622383748761704,['HRAS'],0.9962102205868282,0,0,1
251,Male infertility WP4673,0.9306332998647109,0.36477748193229365,0.02622383748761704,['PEX10'],0.9962102205868282,0,0,1
252,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9306332998647109,0.36477748193229365,0.02622383748761704,['STUB1'],0.9962102205868282,0,0,1
253,Peptide GPCRs WP24,0.9306332998647109,0.36477748193229365,0.02622383748761704,['C5AR1'],0.9962102205868282,0,0,1
254,Insulin Signaling WP481,0.9417957516820517,0.4214939865386737,0.025275667523243252,"['HRAS', 'PFKM']",0.9962102205868282,0,0,2
255,Corticotropin-releasing hormone signaling pathway WP2355,0.9445004890499248,0.3342050209205021,0.019082797305464857,['CRH'],0.9962102205868282,0,0,1
256,Hippo-Merlin Signaling Dysregulation WP4541,0.9445004890499248,0.3342050209205021,0.019082797305464857,['HRAS'],0.9962102205868282,0,0,1
257,Cell cycle WP179,0.9556000156118765,0.30833601544898614,0.014003341361801279,['ANAPC11'],0.9962102205868282,0,0,1
258,Circadian rhythm related genes WP3594,0.9598024914453054,0.38095238095238093,0.015629620481921385,"['CRH', 'RPS27A']",0.9962102205868282,0,0,2
259,Proximal tubule transport WP4917,0.9644833320232264,0.2861625821876868,0.0103484196962879,['SLC7A9'],0.9962102205868282,0,0,1
260,Nuclear Receptors Meta-Pathway WP2882,0.9712783324994405,0.4739300783604581,0.013811368236281292,"['GSTP1', 'MAFF', 'BAX', 'FTL', 'TGFBR2']",0.9962102205868282,0,0,5
261,Metapathway biotransformation Phase I and II WP702,0.9724016959581783,0.3474614893810956,0.009724158855710145,"['GPX4', 'GSTP1']",0.9962102205868282,0,0,2
262,PI3K-Akt signaling pathway WP4172,0.9756071719257542,0.43061166429587483,0.010634067598749346,"['RPS6', 'VEGFB', 'FGF1', 'HRAS']",0.9962102205868282,0,0,4
263,Focal Adhesion WP306,0.9811494505802475,0.3193291404612159,0.006076988699337896,"['VEGFB', 'HRAS']",0.9962102205868282,0,0,2
264,Allograft Rejection WP2328,0.9818315500399839,0.23529411764705882,0.004314240701041261,['HLA-B'],0.9962102205868282,0,0,1
265,TGF-beta Signaling Pathway WP366,0.9818315500399839,0.23529411764705882,0.004314240701041261,['TGFBR2'],0.9962102205868282,0,0,1
266,Adipogenesis WP236,0.9854724033623385,0.22210599721059973,0.0032503336913150844,['DDIT3'],0.9962102205868282,0,0,1
267,Osteoblast differentiation WP4787,0.9883847708846005,0.21030609997797842,0.002457050926079268,['FGF1'],0.9962102205868282,0,0,1
268,Calcium Regulation in the Cardiac Cell WP536,0.9925770894483305,0.19007770472205618,0.0014161924618876956,['RGS16'],0.9962102205868282,0,0,1
269,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9940667936942166,0.18134271586154432,0.001079148325274697,['SST'],0.9962102205868282,0,0,1
270,"GPCRs, Class A Rhodopsin-like WP455",0.994143978796249,0.25671197673632246,0.0015077297490904897,"['GPR22', 'ADRA2A']",0.9962102205868282,0,0,2
271,Vitamin D Receptor Pathway WP2877,0.9962102205868282,0.16605648535564854,0.0006305129582137109,['ZNF257'],0.9962102205868282,0,0,1
